Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

FlexX-Pharm

Neurokinin NKl antagonist 21 Modeller MOBILE FlexX Pharm 11109 leadlike, pharmacophore filtered 1 14.3 — Ki = 251nM [28]... [Pg.386]

Cannabinoid receptor CB2 agonist 18.5 Ligand refined MD FlexX Pharm 1000 diverse, druglike NCI 33 — 11(10) — [40]... [Pg.388]

If not, the solution is discarded. The second type is a spatial constraint. Here, a spherical volume in the active site and a specified atom or group of atoms from the ligand must he within the sphere in the docking solution. FlexX-Pharm [17] offers both constraint types - they even may be combined. [Pg.1183]

See other pages where FlexX-Pharm is mentioned: [Pg.387]    [Pg.391]    [Pg.412]    [Pg.413]    [Pg.42]    [Pg.72]    [Pg.175]    [Pg.264]    [Pg.108]    [Pg.578]    [Pg.162]    [Pg.323]    [Pg.323]    [Pg.333]    [Pg.383]    [Pg.385]    [Pg.497]    [Pg.171]   
See also in sourсe #XX -- [ Pg.387 , Pg.391 , Pg.412 ]

See also in sourсe #XX -- [ Pg.72 ]

See also in sourсe #XX -- [ Pg.175 ]

See also in sourсe #XX -- [ Pg.264 ]

See also in sourсe #XX -- [ Pg.162 , Pg.323 ]

See also in sourсe #XX -- [ Pg.1184 ]



SEARCH



FlexX

© 2024 chempedia.info